Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AKAMAI TECHNOLOGIES INC | 482,957 | reported | 20 May 2018 | tx 167+2,295,508−9,088,987 |
| IRONWOOD PHARMACEUTICALS INC | 62,221 | reported | 03 Jun 2015 | tx 37+68,877−600,808 |
| ORACLE CORP | 38,456 | reported | 17 Jun 2025 | tx 81+852,164−811,594 |
| Cyclerion Therapeutics, Inc. | 20,000 | reported | 14 Jun 2022 | tx 6+54,842 |
| CARDINAL HEALTH INC | 5,617 | reported | 05 Nov 2008 | tx 20+5,786 |
| HARLEY-DAVIDSON, INC. | 0 | reported | 14 Aug 2015 | tx 20+92,453.994−52,573 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2025 | SALE | ORACLE CORP | 8,169 | 213.49 USD | |
| 31 May 2025 | EXERCISE | ORACLE CORP | 2,986 | — | |
| 31 May 2025 | GRANT_AWARD | ORACLE CORP | 2,114 | 0.00 USD | deriv |
| 31 May 2025 | EXERCISE | ORACLE CORP | 2,986 | — | deriv |
| 21 Apr 2025 | EXERCISE | ORACLE CORP | 22,500 | 43.49 USD | |
| 21 Apr 2025 | EXERCISE | ORACLE CORP | 22,500 | 0.00 USD | deriv |
| 31 May 2024 | EXERCISE | ORACLE CORP | 3,303 | — | |
| 31 May 2024 | EXERCISE | ORACLE CORP | 3,303 | — | deriv |
| 31 May 2024 | GRANT_AWARD | ORACLE CORP | 2,986 | 0.00 USD | deriv |
| 03 May 2024 | SALE | ORACLE CORP | 20,000 | 116.00 USD | |
| 03 May 2024 | EXERCISE | ORACLE CORP | 20,000 | 42.02 USD | |
| 03 May 2024 | EXERCISE | ORACLE CORP | 20,000 | 0.00 USD | deriv |
| 01 May 2024 | SALE | ORACLE CORP | 25,000 | 116.13 USD | |
| 01 May 2024 | EXERCISE | ORACLE CORP | 25,000 | 42.02 USD | |
| 01 May 2024 | EXERCISE | ORACLE CORP | 25,000 | 0.00 USD | deriv |
| 13 Nov 2023 | SALE | ORACLE CORP | 2,325 | 113.76 USD | anomaly |
| 10 Nov 2023 | SALE | ORACLE CORP | 2,325 | 111.97 USD | anomaly |
| 31 May 2023 | EXERCISE | ORACLE CORP | 4,866 | — | |
| 31 May 2023 | GRANT_AWARD | ORACLE CORP | 3,303 | 0.00 USD | deriv |
| 31 May 2023 | EXERCISE | ORACLE CORP | 4,866 | — | deriv |
| 22 Dec 2022 | GIFT | ORACLE CORP | 37,500 | 0.00 USD | |
| 14 Jun 2022 | GRANT_AWARD | Cyclerion Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 31 May 2022 | EXERCISE | ORACLE CORP | 4,445 | — | |
| 31 May 2022 | EXERCISE | ORACLE CORP | 4,445 | — | deriv |
| 31 May 2022 | GRANT_AWARD | ORACLE CORP | 4,866 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 06 Jun 2012.